Dr. Jerome H. Goldschmidt, MD
Claim this profileOncology and Hematology Associates of Southwest Virginia, Inc., DBA Blue Ridge Cancer Care
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
7 reported clinical trials
12 drugs studied
Area of expertise
1Lung Cancer
Stage IV
Stage III
NRG1 positive
2Non-Small Cell Lung Cancer
Stage IV
Stage III
KRAS positive
Affiliated Hospitals
Clinical Trials Jerome H. Goldschmidt, MD is currently running
Sigvotatug Vedotin vs Docetaxel
for Lung Cancer
This trial is testing a new drug, sigvotatug vedotin, against a standard drug, docetaxel, in patients with advanced lung cancer. The goal is to see if the new drug works better and to understand its side effects. Docetaxel (Taxotere) is a well-established chemotherapy agent used in the treatment of advanced non-small cell lung cancer (NSCLC), often after failure of first-line treatments.
Recruiting2 awards Phase 35 criteria
Dostarlimab
for Head and Neck Cancer
The goal of this study is to assess the safety and effectiveness of Dostarlimab compared to Placebo in adult participants with HNSCC (Head and Neck Squamous Cell Carcinoma)
Recruiting1 award Phase 3
More about Jerome H. Goldschmidt, MD
Clinical Trial Related11 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Jerome H. Goldschmidt, MD has experience with
- Canakinumab
- Placebo
- Brentuximab Vedotin
- Avutometinib (VS-6766)
- Sotorasib
- SGN-B6A
Breakdown of trials Jerome H. Goldschmidt, MD has run
Lung Cancer
Non-Small Cell Lung Cancer
- Combination Immunotherapies for Non-Small Cell Lung Cancer
- Sigvotatug Vedotin vs Docetaxel for Lung Cancer
- Brief Title: Study of Efficacy and Safety of Canakinumab as Adjuvant Therapy in Adult Subjects With Stages AJCC/UICC v. 8 II-IIIA and IIIB (T>5cm N2) Completely Resected Non-small Cell Lung Cancer Acronym: CANOPY-A
Head and Neck Cancers
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jerome H. Goldschmidt, MD specialize in?
Jerome H. Goldschmidt, MD focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage IV patients, or patients who are Stage III.
Is Jerome H. Goldschmidt, MD currently recruiting for clinical trials?
Yes, Jerome H. Goldschmidt, MD is currently recruiting for 3 clinical trials in Blacksburg Virginia. If you're interested in participating, you should apply.
Are there any treatments that Jerome H. Goldschmidt, MD has studied deeply?
Yes, Jerome H. Goldschmidt, MD has studied treatments such as Canakinumab, Placebo, Brentuximab Vedotin.
What is the best way to schedule an appointment with Jerome H. Goldschmidt, MD?
Apply for one of the trials that Jerome H. Goldschmidt, MD is conducting.
What is the office address of Jerome H. Goldschmidt, MD?
The office of Jerome H. Goldschmidt, MD is located at: Oncology and Hematology Associates of Southwest Virginia, Inc., DBA Blue Ridge Cancer Care, Blacksburg, Virginia 24060 United States. This is the address for their practice at the Oncology and Hematology Associates of Southwest Virginia, Inc., DBA Blue Ridge Cancer Care.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.